Capital Research Global Investors
MJN

Capital Research Global Investors’s Mead Johnson Nutrition Company MJN Stock Holding History

Capital Research Global Investors’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-5,888,670
Closed -$525M – 452
2017
Q1 		$525M Sell
5,888,670
-4,869,892
-45% -$401M 0.17% 141
2016
Q4 		$761M Sell
10,758,562
-2,499,980
-19% -$186M 0.25% 106
2016
Q3 		$1.05B Sell
13,258,542
-1,428
-0% -$122K 0.35% 73
2016
Q2 		$1.2B Sell
13,259,970
-178,816
-1% -$15.1M 0.41% 66
2016
Q1 		$1.14B Sell
13,438,786
-1,143,000
-8% -$85M 0.39% 72
2015
Q4 		$1.15B Buy
14,581,786
+466,232
+3% +$36.7M 0.39% 67
2015
Q3 		$994M Buy
14,115,554
+2,294,720
+19% +$189M 0.36% 72
2015
Q2 		$1.07B Buy
11,820,834
+4,289,993
+57% +$414M 0.35% 77
2015
Q1 		$757M Hold
7,530,841
– – 0.26% 102
2014
Q4 		$757M Sell
7,530,841
-583,845
-7% -$58.2M 0.26% 101
2014
Q3 		$781M Sell
8,114,686
-423,155
-5% -$40.1M 0.27% 97
2014
Q2 		$795M Buy
8,537,841
+600,000
+8% +$52.5M 0.28% 102
2014
Q1 		$660M Buy
7,937,841
+244,292
+3% +$19.8M 0.24% 113
2013
Q4 		$644M Buy
7,693,549
+196,240
+3% +$16M 0.24% 115
2013
Q3 		$557M Buy
7,497,309
+4,711,741
+169% +$353M 0.22% 115
2013
Q2 		$221M Buy
+2,785,568
New +$223M 0.09% 195

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.55B AUM 27.24% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.54B AUM 37.12% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Capital Research Global Investors's MJN Position: Q2 2017 in Review

Capital Research Global Investors sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 5,888,670 shares — an estimated $525M sold.

Capital Research Global Investors first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $1.2B in Q2 2016. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Capital Research Global Investors reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Capital Research Global Investors sold 5,888,670 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $525M.
  • Capital Research Global Investors first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • Capital Research Global Investors's Mead Johnson Nutrition Company position peaked at $1.2B in Q2 2016.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Capital Research Global Investors's 13F filing for Q2 2017, filed 14 Aug 2017.